← FDA DRUG APPROVALS

FDA NDA · NDA009088

NEOTHYLLINE

Sponsor: TEVA

APPLICATION
NDA009088
TYPE
NDA
ORIGINAL APPROVAL
1953-09-28
LATEST ACTION
1998-05-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NEOTHYLLINEDiscontinued
DYPHYLLINE 250MG/ML · INJECTABLE · INJECTION

Approval history

1998-05-12Labeling · Supplement 4AP
1998-05-12Labeling · Supplement 6AP
1953-09-28Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →